Bulletin
Investor Alert

Rigel Pharmaceuticals Inc.

NAS: RIGL

GO
/marketstate/country/us

After Hours

/zigman2/quotes/207222917/composite

$

3.24

Change

0.00 0.00%

Volume

Volume 56,389

Oct 22, 2021, 4:38 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/207222917/composite

Previous close

$ 3.28

$ 3.24

Change

-0.04 -1.22%

Day low

Day high

$3.19

$3.25

Open
Open: 3.24

52 week low

52 week high

$2.36

$5.50

Open

Market cap

$553.56M

Average volume

1.26M

P/E ratio

N/A

Rev. per Employee

$642,728

EPS

-0.05

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rigl

MarketWatch News on RIGL

  1. Rising drug prices continue to hit seniors

    6:05 a.m. July 6, 2021

    - Paul Brandus

  2. Riell shares jump 31% premarket

    7:38 a.m. Feb. 18, 2021

    - Ciara Linnane

  3. Eli Lilly to pay Rigel $125 mln upfront, up to $835 mln in future milestone payments

    7:37 a.m. Feb. 18, 2021

    - Ciara Linnane

  4. Eli Lilly and Rigel to codevelop Rigel's treatment for immunological and neurodegenerative diseases

    7:37 a.m. Feb. 18, 2021

    - Ciara Linnane

  5. Rigel Pharmaceuticals downgraded to neutral and overweight at J.P. Morgan

    10:27 a.m. Nov. 9, 2020

    - Tomi Kilgore

  6. Rigel Pharmaceuticals downgraded to neutral from overweight at J.P. Morgan

    8:05 a.m. Nov. 9, 2020

    - Tomi Kilgore

  7. Rigel Pharmaceuticals stock price target raised to $7 from $6 at J.P. Morgan

    7:26 a.m. Sept. 4, 2018

    - Tomi Kilgore

  8. Rigel Pharmaceuticals stock price target raised to $8 from $6 at BMO Capital

    9:26 a.m. April 18, 2018

    - Tomi Kilgore

  9. Rigel announces FDA approval, for real this time

    5:35 p.m. April 17, 2018

    - Jeremy C. Owens

  10. News that made Rigel stock pop was a mistake, Rigel says

    4:29 p.m. April 12, 2018

    - Jeremy C. Owens

  11. Rigel Pharmaceuticals CFO Ryan Maynard resigns after 7 1/2-years in the role

    8:35 a.m. Dec. 15, 2017

    - Tomi Kilgore

  12. Barron’s After Hours: Hess Jumps, Jabil Gains, Oracle Sinks

    9:31 p.m. Dec. 14, 2017

    - Barrons Blogs

  13. Charting the Market

    1:46 a.m. Oct. 7, 2017

    - Barron's Online

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rigl

Other News on RIGL

  1. Rigel (RIGL) COVID-19 Treatment Denied By FDA for EUA

    10:27 a.m. Aug. 16, 2021

    - Zacks.com

  2. SoFi Technologies, Cricut, FIGS among premarket losers' pack

    8:54 a.m. Aug. 13, 2021

    - Seeking Alpha

  3. 10-Q: RIGEL PHARMACEUTICALS INC

    4:08 p.m. Aug. 3, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  4. Rigel Pharmaceuticals EPS beats by $0.04, beats on revenue

    4:07 p.m. Aug. 3, 2021

    - Seeking Alpha

  5. 3 Biotech Stocks That Could Rocket Higher

    6:37 a.m. July 24, 2021

    - Motley Fool

  6. A Recommendation For Rigel Pharmaceuticals

    10:42 a.m. May 16, 2021

    - Seeking Alpha

  7. Loading more headlines...
/news/pressrelease/company/us/rigl

Press Releases on RIGL

  1. Rigel to Participate in Three Upcoming Investor Conferences

    7:30 a.m. Sept. 2, 2021

    - PR Newswire - PRF

  2. Rigel Pharmaceuticals Provides Update on COVID-19 Program

    7:30 a.m. Aug. 13, 2021

    - PR Newswire - PRF

  3. Top Biotech Penny Stocks to Buy This Week? 9 To Watch

    2:36 p.m. July 6, 2021

    - Penny Stocks

  4. Fostamatinib Selected for NIH ACTIV-4 COVID-19 Clinical Trial

    7:30 a.m. June 29, 2021

    - PR Newswire - PRF

  5. Top Penny Stocks to Buy in July? 7 You May Not Know About

    4:06 p.m. June 28, 2021

    - Penny Stocks

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.